Athelas Stock
HealthTechLooking to sell Athelas stock or options?
Athelas has developed an in-home blood diagnostic device intended to track the immune system using just a drop of blood. This device features a portable optical unit that captures sample images, analyzes blood cells, and produces diagnostic reports. It allows patients to monitor their immunity levels from home while assisting doctors in early detection of conditions such as leukemia, infections, and inflammatory diseases.
Sequoia Capital, Initialized Capital Management, Human Capital, Cardinal Ventures, Greenoaks Capital Partners, USC Marshall School of Business, Fifty Years, Charles Reim, Shasta Ventures, Patrick Yang, Qasar Younis, Liquid 2 Ventures, General Catalyst, James Hong, LYVC, CSC UpShot Ventures, Georges Harik, Richard Socher, Joshua Buckley, Y Combinator, Dorm Room Fund, Elad Gil, Browder Capital, Tribe Capital, AIX Ventures.